Visa-Mastercard Deal, Winrevair Approval, & a Wolf in Sheep's Clothing | March 27, 2024 – Morning Market Briefing

from The Morning Market Briefing · host Narwhal Capital Management

Visa and MasterCard reach a $30 billion deal with US retailers, Merck receives FDA approval for Winrevair in the US, and why the Artisan Developing World Fund is a wolf in sheep's clothing. For information on how to join the Zoom calls live each morning at 8:30 EST, visit https://www.narwhalcapital.com/blog/daily-market-briefingsPlease see disclosures:https://www.narwhalcapital.com/disclosure

Episode metadata supplied by the publisher feed · Published Mar 27, 2024

Embed this episode

Attribution link and audio player

Ready to play

Visa-Mastercard Deal, Winrevair Approval, & a Wolf in Sheep's Clothing | March 27, 2024 – Morning Market Briefing

0:00 17:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Morning Market Briefing?

This episode is 17 minutes long.

When was this The Morning Market Briefing episode published?

This episode was published on March 27, 2024.

Can I download this The Morning Market Briefing episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!